NOTE 5 - STOCKHOLDERS EQUITY | On July 4, 2017, a private placement exercise was completed with issuance of the balance of shares (70,115,000 shares) within our authorized capital to our existing directors for total cash consideration of $70,115. The cash was held in escrow as of August 31, 2017. On the 7th and 17th of August 2017, the Company had filed Schedule Pre-14C and Def-14c for an increase in our authorized capital from 75,000,000 shares to 1,000,000,000 (one billion) shares of common stock at par value of $0.001 per share following a written consent of majority shareholders on the matter on August 1, 2017. Following the above, on September 19, 2017 amendments to the Company’s Articles of Incorporation had been filed with the Nevada Secretary of State thus increasing the Company’s authorized capital from 75,000,000 shares to 1,000,000,000 (one billion) shares of common stock at par value of $0.001 per share. On May 25, 2018, our new President & CEO Mr. Yap Kit Chuan entered into a Share Purchase Agreement with ex-director Prof. Dr. Wong Kong Yew to transfer all shares-holdings of Prof. Dr. Wong Kong Yew (70,414,500 restricted shares) to Mr. Yap Kit Chuan at a token consideration of $250. The shares will remain as restricted shares after the transfer. Subsequently on June 19, 2018 our transfer agent, Globex Transfer, LLC registered the change and issued the new restricted share certificate. No Name Affiliation No. of Existing Shares Existing Share-holdings After Transfer of Shares Shareholdings after Placement 1. Yap Kit Chuan President, CEO, Secretary & Chairman of the Board of Directors 1,525,000 2.03 % 71,939,500 95.92 % 2. Huang Minxi Director 1,295,500 1.73 % 1,295,500 1.73 % 3. Wong Kong Yew Ex-Director 70,414,500 93.89 % 0 0.00 % 73,235,000 97.65 % 73,235,000 97.65 % |